# Medtronic Vascular clinical trials: 60 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 60 trials with Medtronic Vascular as lead sponsor, 7 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Medtronic Vascular: 60 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/medtronic-vascular

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 60
- Recruiting or not yet: 7
- Read on: November 19, 2026

## Trials

The 25 newest of 60, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 16, 2025 | NCT07174622 | Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation | Medtronic Vascular | Observational | Recruiting | Hypertension, Cardiovascular Diseases, Vascular Diseases | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07174622) |
| August 11, 2025 | NCT07115953 | Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension | Medtronic Vascular | Not applicable | Recruiting | Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07115953) |
| July 23, 2025 | NCT07081243 | Symplicity China Study | Medtronic Vascular | Observational | Recruiting | Resistant Hypertension | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07081243) |
| June 10, 2025 | NCT07013929 | Spyral InSight Study | Medtronic Vascular | Not applicable | Recruiting | Hypertension, Vascular Diseases, Cardiovascular Diseases | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07013929) |
| April 2, 2025 | NCT06907147 | SPYRAL GEMINI Pilot Study | Medtronic Vascular | Not applicable | Recruiting | Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus | 175 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06907147) |
| August 2, 2024 | NCT06535854 | Prevail Global Study | Medtronic Vascular | Not applicable | Recruiting | Coronary Artery Disease | 1,205 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06535854) |
| January 20, 2022 | NCT05198674 | SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN | Medtronic Vascular | Not applicable | Active not recruiting | Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus | 1,899 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05198674) |
| March 17, 2020 | NCT04311086 | SPYRAL DYSTAL Renal Denervation Global Clinical Study | Medtronic Vascular | Not applicable | Completed | Hypertension, Vascular Diseases, Cardiovascular Diseases | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04311086) |
| August 27, 2018 | NCT03647475 | A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear) | Medtronic Vascular | Not applicable | Completed | Coronary Artery Disease | 752 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03647475) |
| July 12, 2018 | NCT03584464 | RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort) | Medtronic Vascular | Not applicable | Completed | Coronary Artery Disease | 205 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03584464) |
| March 21, 2018 | NCT03471845 | RESOLUTE ONYX China Single Arm Study | Medtronic Vascular | Not applicable | Completed | Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases, Arteriosclerosis, Coronary Artery Disease | 591 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03471845) |
| March 15, 2018 | NCT03466151 | RESOLUTE ONYX China RCT Study | Medtronic Vascular | Not applicable | Completed | Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases, Arteriosclerosis, Coronary Artery Disease | 550 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03466151) |
| November 17, 2017 | NCT03344653 | A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients | Medtronic Vascular | Not applicable | Completed | Coronary Artery Disease | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03344653) |
| August 24, 2017 | NCT03260517 | The PREVAIL Study | Medtronic Vascular | Not applicable | Completed | In-stent Restenosis, Ischemic Heart Disease, Coronary Artery Disease | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03260517) |
| April 18, 2017 | NCT03118531 | China Resolute Integrity 34/38 mm Study | Medtronic Vascular | Not applicable | Completed | Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases, Arteriosclerosis, Coronary Artery Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03118531) |
| February 24, 2017 | NCT03063749 | RESOLUTE ONYX Post-Approval Study | Medtronic Vascular | Observational | Completed | Coronary Artery Disease | 416 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03063749) |
| June 24, 2015 | NCT02480348 | Medtronic RevElution Trial | Medtronic Vascular | Not applicable | Completed | Coronary Artery Disease | 109 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02480348) |
| May 25, 2015 | NCT02452736 | Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment... | Medtronic Vascular | Phase 3 | Completed | Ischemic Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Coronary Artery Disease | 205 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02452736) |
| May 12, 2015 | NCT02439775 | SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System | Medtronic Vascular | Not applicable | Completed | Hypertension, Vascular Diseases, Cardiovascular Diseases | 337 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02439775) |
| May 12, 2015 | NCT02439749 | SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study | Medtronic Vascular | Not applicable | Completed | Hypertension, Vascular Diseases, Cardiovascular Diseases | 366 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02439749) |
| April 17, 2015 | NCT02419521 | Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study | Medtronic Vascular | Not applicable | Completed | Coronary Artery Disease | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02419521) |
| April 9, 2015 | NCT02412501 | Medtronic Resolute Onyx 2.0 mm Clinical Study | Medtronic Vascular | Not applicable | Completed | Coronary Artery Disease | 101 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02412501) |
| February 17, 2014 | NCT02064764 | Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation | Medtronic Vascular | Not applicable | Completed | Atrial Fibrillation, Hypertension | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02064764) |
| October 30, 2013 | NCT01972139 | Renal Denervation in Patients With Uncontrolled Hypertension - SYMPLICITY HTN-4 | Medtronic Vascular | Not applicable | Completed | Hypertension, Vascular Diseases, Cardiovascular Diseases | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01972139) |
| August 1, 2013 | NCT01913600 | Resolute Integrity US Extended Length Sub-Study(RI US XL) | Medtronic Vascular | Not applicable | Completed | Coronary Artery Disease | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01913600) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 3 |
| Phase 1/2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 4 |
| Not applicable | 42 |
| Observational | 9 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 50 |
| Recruiting | 7 |
| Terminated | 2 |
| Active not recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Coronary Artery Disease | 34 |
| Cardiovascular Diseases | 21 |
| Hypertension | 16 |
| Myocardial Ischemia | 15 |
| Vascular Diseases | 12 |
| Myocardial Infarction | 10 |
| Arteriosclerosis | 8 |
| Arterial Occlusive Diseases | 4 |
| Coronary Disease | 3 |
| Heart Diseases | 3 |
| Renal Insufficiency, Chronic | 3 |
| Diabetes Mellitus | 3 |
| Kidney Failure, Chronic | 2 |
| Renal Insufficiency | 2 |
| Coronary Stenosis | 1 |
| Ischemia | 1 |
| Coronary Artery Disease, Autosomal Dominant, 1 | 1 |
| Chronic Disease | 1 |
| Disease Attributes | 1 |
| Pathologic Processes | 1 |
| Kidney Diseases | 1 |
| Angina, Stable | 1 |
| Heart Failure | 1 |
| Atrial Fibrillation | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Fire and water damage restoration companies in the United States](https://specstream.ai/data/businesses/fire-and-water-damage-restoration-companies/united-states)
- [Internet service providers in the United States](https://specstream.ai/data/businesses/internet-service-providers/united-states)
- [Occupational safety services in the United States](https://specstream.ai/data/businesses/occupational-safety-services/united-states)
- [Records storage companies in the United States](https://specstream.ai/data/businesses/records-storage-companies/united-states)
- [Tractor dealers in the United States](https://specstream.ai/data/businesses/tractor-dealers/united-states)
- [Asian fusion restaurants in the United States](https://specstream.ai/data/businesses/asian-fusion-restaurants/united-states)
